{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:40:08Z","timestamp":1782132008742,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key projects of Chongqing Health and Family Planning Commission","award":["2019ZDXM011"],"award-info":[{"award-number":["2019ZDXM011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Carcinoembryonic antigen (CEA) is not only used to aid the diagnosis of lung cancer, but also help monitor recurrence and determine the prognosis of lung cancer as well as evaluate the therapeutic efficacy for lung cancer. However, studies have also shown that CEA is present at low levels in the serum of patients with benign lung diseases (BLD), which will interfere with the accurate judgment of the disease. Due to difference in sample size, detection methods, cutoff values and sources of BLD, the positive rate of CEA in BLD is different with different literature. Therefore, it is necessary to define CEA levels in patients of different BLD in a large sample study. 4796 patients with BLD were included in this study. The results showed that the CEA levels of 3.1% (149\/4796) patients with BLD were elevated, with three cases exceeds 20\u00a0ng\/mL (0.06%, 3\/4796). The results from the literature showed that BLD had a mean positive rate of 5.99% (53\/885) and only two cases had CEA above 20\u00a0ng\/mL. The CEA elevations mainly distributed in chronic obstructive pulmonary disease (COPD), pneumonitis and interstitial lung disease and significantly correlated with age of patients (OR 2.69, 95% CI 1.94\u20133.73, p\u2009&lt;\u20090.001). Pulmonary tuberculosis (7\/1311, 0.53%) had the lowest positive rate of CEA elevations while pulmonary alveolar proteinosis (6\/27, 22.22%) had the highest positive rate. The majority of patients with abnormally elevated CEA levels had multiple underlying diseases, mainly diseases of the circulatory system (42.28% [63\/149]), endocrine diseases (26.85% [40\/149]), and respiratory or heart failure (24.16% [36\/149]. In endocrine diseases, 87.5% (35\/40) of patients had diabetes. In conclusion, CEA is present at a low positive rate in the serum of patients with BLD, but few exceed 20\u00a0ng\/mL. For lung disease patients, if CEA levels rise, we should carry out comprehensive analysis of types of lung diseases, age of patients, and comorbid diseases.<\/jats:p>","DOI":"10.1038\/s41598-021-98513-8","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T20:06:05Z","timestamp":1632945965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serum carcinoembryonic antigen elevation in benign lung diseases"],"prefix":"10.1038","volume":"11","author":[{"given":"Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjie","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"98513_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.lungcan.2011.11.012","volume":"762","author":"M Grunnet","year":"2012","unstructured":"Grunnet, M. & Sorensen, J. B. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 762, 138\u2013143 (2012).","journal-title":"Lung Cancer"},{"key":"98513_CR2","first-page":"4550","volume":"17","author":"G He","year":"2019","unstructured":"He, G., Jiang, Z., Xue, S., Sun, X. & Wang, W. Expression of LDH and CEA in serum in the process of targeted therapy of lung adenocarcinoma and the association between them and prognosis. Oncol. Lett. 17, 4550\u20134556 (2019).","journal-title":"Oncol. Lett."},{"key":"98513_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/1471-2407-13-254","volume":"13","author":"O Arrieta","year":"2013","unstructured":"Arrieta, O. et al. Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: A prospective cohort study. BMC Cancer 13, 254 (2013).","journal-title":"BMC Cancer"},{"key":"98513_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.ejca.2005.03.011","volume":"41","author":"T Okamoto","year":"2005","unstructured":"Okamoto, T., Nakamura, T. & Ikeda, J. Serum carcinoembryonic antigen as a predictive marker for sensitivity to gefitinib in advanced non-small cell lung cancer. Eur. J. Cancer. 41, 1286\u20131290 (2005).","journal-title":"Eur. J. Cancer."},{"key":"98513_CR5","first-page":"61","volume":"20","author":"XC Gao","year":"2020","unstructured":"Gao, X. C. et al. 18F-FDG PET\/CT SUVmax and serum CEA levels as predictors for EGFR mutation state in Chinese patients with non-small cell lung cancer. Oncol. Lett. 20, 61 (2020).","journal-title":"Oncol. Lett."},{"key":"98513_CR6","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/s41598-020-59031-1","volume":"10","author":"YS Kuo","year":"2020","unstructured":"Kuo, Y. S. et al. Association of divergent carcinoembryonic antigen patterns and lung cancer progression. Sci. Rep. 10, 2066 (2020).","journal-title":"Sci. Rep."},{"key":"98513_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/172460089200700307","volume":"7","author":"MA Ruibal","year":"1992","unstructured":"Ruibal, M. A. CEA serum levels in non-neoplastic disease. Int. J. Biol. Markers. 7, 160\u2013166 (1992).","journal-title":"Int. J. Biol. Markers."},{"key":"98513_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ejcts\/ezy170","volume":"54","author":"WS Yu","year":"2018","unstructured":"Yu, W. S. et al. Carcinoembryonic antigen predicts waitlist mortality in lung transplant candidates with idiopathic pulmonary fibrosis. Eur. J. Cardiothorac. Surg. 54, 847\u2013852 (2018).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"98513_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5761\/atcs.cr.17-00092","volume":"24","author":"H Komatsu","year":"2018","unstructured":"Komatsu, H. et al. Elevation of serum carcinoembryonic antigen concentration caused by everolimus-induced lung injury: A case report. Ann. Thorac. Cardiovasc. Surg. 24, 151\u2013153 (2018).","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"98513_CR10","first-page":"885","volume":"23","author":"J Schneider","year":"2003","unstructured":"Schneider, J., Philipp, M., Velcovsky, H. G., Morr, H. & Katz, N. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21\u20131) in patients with lung cancer in comparison to other lung diseases. Anticancer Res. 23, 885\u2013893 (2003).","journal-title":"Anticancer Res."},{"key":"98513_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/1477-3163.170662","volume":"14","author":"SK Sharma","year":"2015","unstructured":"Sharma, S. K. et al. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer. J. Carcinog. 14, 7 (2015).","journal-title":"J. Carcinog."},{"key":"98513_CR12","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.7314\/APJCP.2014.15.22.9611","volume":"15","author":"B Wang","year":"2014","unstructured":"Wang, B. et al. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer. Asian Pac. J. Cancer Prev. 15, 9611\u20139614 (2014).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"98513_CR13","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/clinchem\/48.11.1931","volume":"48","author":"J Kulpa","year":"2002","unstructured":"Kulpa, J., W\u00f3jcik, E., Reinfuss, M. & Ko\u0142odziejski, L. Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21\u20131, and neuron-specific enolase in squamous cell lung cancer patients. Clin. Chem. 48, 1931\u20131937 (2002).","journal-title":"Clin. Chem."},{"key":"98513_CR14","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R","volume":"82","author":"B Nisman","year":"1998","unstructured":"Nisman, B. et al. Evaluation of tissue polypeptide specific antigen, CYFRA 21\u20131, and carcinoembryonic antigen in nonsmall cell lung carcinoma: Does the combined use of cytokeratin markers give any additional information?. Cancer 82, 1850\u20131859 (1998).","journal-title":"Cancer"},{"key":"98513_CR15","first-page":"3244","volume":"124","author":"WA Song","year":"2011","unstructured":"Song, W. A. et al. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21\u20131 and neuron specific enolase in lung cancer diagnosis: A prospective study from China. Chin. Med. J. 124, 3244\u20133248 (2011).","journal-title":"Chin. Med. J."},{"key":"98513_CR16","first-page":"159","volume":"43","author":"P Berzinec","year":"1996","unstructured":"Berzinec, P., Zuffov\u00e1, H., Letkovicov\u00e1, M. & Arp\u00e1sov\u00e1, M. Serum tumor marker CYFRA 21\u20131 in the diagnostics of squamous cell lung cancer-comparison with CEA. Neoplasma 43, 159\u2013161 (1996).","journal-title":"Neoplasma"},{"key":"98513_CR17","first-page":"361","volume":"32","author":"C Gruber","year":"2008","unstructured":"Gruber, C., Hatz, R., Reinmiedl, J., Nagel, D. & Stieber, P. CEA, CYFRA 21\u20131, NSE, and ProGRP in the diagnosis of lung cancer: a multivariate approach. J. Lab. Med. 32, 361\u2013371 (2008).","journal-title":"J. Lab. Med."},{"key":"98513_CR18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1440-1843.2012.02231.x","volume":"17","author":"A Fahim","year":"2012","unstructured":"Fahim, A. et al. Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis. Respirology 17, 1247\u20131252 (2012).","journal-title":"Respirology"},{"key":"98513_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ssu.2980070309","volume":"7","author":"AH Chevinsky","year":"1991","unstructured":"Chevinsky, A. H. CEA in tumors of other than colorectal origin. Semin. Surg. Oncol. 7, 162\u2013166 (1991).","journal-title":"Semin. Surg. Oncol."},{"key":"98513_CR20","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1001\/jama.1976.03260440027017","volume":"235","author":"JC Alexander","year":"1976","unstructured":"Alexander, J. C., Silverman, N. A. & Chretien, P. B. Effect of age and cigarette smoking on carcinoembryonic antigen levels. JAMA 235, 1975\u20131979 (1976).","journal-title":"JAMA"},{"key":"98513_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/bs.pmbts.2018.12.011","volume":"162","author":"C Hao","year":"2019","unstructured":"Hao, C., Zhang, G. & Zhang, L. Serum CEA levels in 49 different types of cancer and noncancer diseases. Prog. Mol. Biol. Transl. Sci. 162, 213\u2013227 (2019).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"98513_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1900\/RDS.2019.15.1","volume":"15","author":"J Khateeb","year":"2019","unstructured":"Khateeb, J., Fuchs, E. & Khamaisi, M. Diabetes and lung disease: A neglected relationship. Rev. Diabet. Stud. 15, 1\u201315 (2019).","journal-title":"Rev. Diabet. Stud."},{"key":"98513_CR23","first-page":"968","volume":"27","author":"F Tanaka","year":"1989","unstructured":"Tanaka, F. et al. A case of pulmonary alveolar proteinosis accompanied with the elevation of CEA (carcinoembryonic antigen) in bronchoalveolar lavage fluid. Nihon Kyobu Shikkan Gakkai Zasshi 27, 968\u2013973 (1989).","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"98513_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/A:1022643102208","volume":"22","author":"I Fukuda","year":"1998","unstructured":"Fukuda, I., Yamakado, M. & Kiyose, H. Influence of smoking on serum carcinoembryonic antigen levels in subjects who underwent multiphasic health testing and services. J. Med. Syst. 22, 89\u201393 (1998).","journal-title":"J. Med. Syst."},{"key":"98513_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/BF01295116","volume":"28","author":"P Thomas","year":"1983","unstructured":"Thomas, P. & Zamcheck, N. Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA). Dig. Dis. Sci. 28, 216\u2013224 (1983).","journal-title":"Dig. Dis. Sci."},{"key":"98513_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jlb.45.4.370","volume":"45","author":"CA Toth","year":"1989","unstructured":"Toth, C. A., Rapoza, A., Zamcheck, N., Steele, G. & Thomas, P. Receptor-mediated endocytosis of carcinoembryonic antigen by rat alveolar macrophages in vitro. J. Leukoc. Biol. 45, 370\u2013376 (1989).","journal-title":"J. Leukoc. Biol."},{"key":"98513_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10585-017-9838-x","volume":"34","author":"AM Mohr","year":"2017","unstructured":"Mohr, A. M. et al. Enhanced colorectal cancer metastases in the alcohol-injured liver. Clin. Exp. Metastasis. 34, 171\u2013184 (2017).","journal-title":"Clin. Exp. Metastasis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98513-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:02:50Z","timestamp":1670083370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98513-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98513"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98513-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"3 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19044"}}